跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
diphtheria/tetanus/acellular pertussis vaccine
首页
药物
diphtheria/tetanus/acellular pertussis vaccine
diphtheria/tetanus/acellular pertussis vaccine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
Preparation method for absorbed acellular diphtheria, tetanus and pertussis combined vaccine
申请人: CHENGDU KANGHUA BIOLOG PROD CO
优先权: 2011
CN
Preparation of domestic adsorhed diphtheria tetanus and acellular pertussis combined vaccine without formaldehyde and merthiolate
申请人: ZHEJIANG WEIXIN BIOLOG PHARMAC
优先权: 2008
CN
Combined vaccine for adsorbing Diphtheria, tetanus and acellular pertussis-Sabin inactivated poliovirus and preparation thereof
申请人: CHINESE ACAD MED SCIENCE
优先权: 2011
CN
Preparation method of adsorbed diphtheria, tetanus and acellular pertussis and hemophilus influenza type B tetravalent combined vaccine
申请人: CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO LTD
优先权: 2017
CN
Separated and purified acellular pertussis-diphtheria-tetanus, b-type haemophilus influenzae and A-group and C-group meningococcus combined vaccine and preparation method thereof
申请人: OLYMVAX BIOPHARMACEUTICALS INC
优先权: 2015
CN
Pneumococcus-DPT combined vaccine
申请人: BRAVOVAX CO LTD
优先权: 2016
CN
Acellular pertussis combined vaccine for adults and teenagers and preparation method of acellular pertussis combined vaccine
申请人: CHINESE ACADEMY OF MEDICAL SCIENCES INST OF MEDICAL BIOLOGY
优先权: 2022
CN
Acellular pertussis combined vaccine and preparation method thereof
申请人: OLYMVAX BIOPHARMACEUTICALS INC
优先权: 2015
CN
药物
反馈
